← Eichor
Condition: Promyelocytic Leukemia Adult Acute Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Promyelocytic Leukemia Adult Acute

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractor
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT02390752Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Phase 3 · 12 location(s) · Quetzal Therapeutics · NCT07504458RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Phase N/A · 6 location(s) · Grupo Argentino de Tratamiento de la Leucemia Aguda · NCT04897490
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.